beta blockers

Some patients who received beta-blockers before and around the time of undergoing non-cardiac surgery appear to have higher rates of heart attack and death within 30 days of their surgery, according to a new report.

Researchers in the UK are developing new drug that could ease the suffering of hundreds of thousands of heart disease patients who are unable to take beta-blockers.

(University of Nottingham) Researchers at the University of Nottingham have been awarded £2.8 million by the Wellcome Trust to develop a new drug that could ease the suffering of hundreds of thousands of heart disease patients who are unable to take beta-blockers.

A genetic variation, found predominantly in African Americans, protects some people with heart failure, enabling them to live longer than expected.

Researchers found that the genetic variation acts just like beta-blockers, a class of drugs used to treat chronic heart failure.

The researchers say their discovery adds to the accumulating evidence that genetic differences contribute to the way people respond to medications.

About 40 percent of African-Americans have a genetic variant that can protect them after heart failure and prolong their lives, according to new research.

The new study offers a reason why beta blockers don't appear to benefit some African-Americans.

A genetic variation, found predominantly in African Americans, protects some people with heart failure, enabling them to live longer than expected.

Researchers found that the genetic variation acts just like beta-blockers, a class of drugs used to treat chronic heart failure.

The researchers say their discovery adds to the accumulating evidence that genetic differences contribute to the way people respond to medications.

One month of tough breathing may help asthma sufferers breathe easier in the long run with a pharmacology professor relying on a medical taboo to treat asthma.

Although counterintuitive, these studies are like hair-of-the-dog folk wisdom -- treating like with like -- using beta blockers instead of stimulants in asthmatics.

Termed "paradoxical pharmacology" -- treating patients with medicine that initially worsens their symptoms before eventually improving their overall health -- the studies have moved into human clinical trials.

One month of tough breathing may help asthma sufferers breathe easier in the long run with a UH pharmacology professor relying on a medical taboo to treat asthma.

Although counterintuitive, these studies are like hair-of-the-dog folk wisdom -- treating like with like -- using beta blockers instead of stimulants in asthmatics.

Termed "paradoxical pharmacology" -- treating patients with medicine that initially worsens their symptoms before eventually improving their overall health -- the studies have moved into human clinical trials.

Women and men experience a similar prevalence of adverse drug reactions in the treatment of coronary artery disease; however, women are significantly less likely than their male counterparts to be treated with statins, aspirin, and beta-blockers according to a new study.